Amedisys, Inc.
General ticker "AMED" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $3.1B (TTM average)
Amedisys, Inc. does not follow the US Stock Market performance with the rate: -10.5%.
Estimated limits based on current volatility of 0.2%: low 97.68$, high 98.13$
Factors to consider:
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [67.72$, 108.77$]
- 2025-12-31 to 2026-12-31 estimated range: [54.81$, 92.12$]
Financial Metrics affecting the AMED estimates:
- Negative: Interest expense per share, $ of 0.94 > 0.68
- Positive: Non-GAAP EPS, $ of 4.31 > 2.19
- Negative: 42.99 < Shareholder equity ratio, % of 53.05 <= 63.58
- Negative: -0.32 < Industry inventory ratio change (median), % of 0
- Negative: Operating cash flow per share per price, % of 7.84 <= 12.74
- Negative: Investing cash flow per share, $ of -0.26 <= -0.10
Short-term AMED quotes
Long-term AMED plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,223.20MM | $2,236.38MM | $2,348.32MM |
| Operating Expenses | $2,042.43MM | $2,079.99MM | $2,253.79MM |
| Operating Income | $180.77MM | $156.39MM | $94.54MM |
| Non-Operating Income | $-20.53MM | $-116.77MM | $-8.32MM |
| Interest Expense | $22.23MM | $31.27MM | $30.76MM |
| Income(Loss) | $160.24MM | $39.62MM | $86.22MM |
| Taxes | $42.55MM | $50.56MM | $48.05MM |
| Profit(Loss)* | $118.61MM | $-9.75MM | $43.23MM |
| Stockholders Equity | $1,051.57MM | $1,066.51MM | $1,134.54MM |
| Inventory | $25.22MM | $0.00MM | $0.00MM |
| Assets | $1,976.24MM | $2,060.17MM | $2,138.71MM |
| Operating Cash Flow | $133.28MM | $137.19MM | $221.66MM |
| Capital expenditure | $7.21MM | $12.71MM | $6.55MM |
| Investing Cash Flow | $-94.49MM | $35.06MM | $-8.36MM |
| Financing Cash Flow | $-30.43MM | $-87.52MM | $-48.92MM |
| Earnings Per Share** | $3.65 | $-0.30 | $1.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.